Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE0006632003
Tue, 13.10.2020
MorphoSys AG
Ad hoc release according to article 17 para. 1 MAR
Planegg/Munich, Germany, October 13, 2020
Ad hoc: MorphoSys AG Launches an Offering of approx.EUR 325 Million Convertible Bonds
MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) today announces to launch an offering of unsubordinated, unsecured convertible bonds d [ … ]
Sat, 01.08.2020
MorphoSys AG
Ad hoc release according to article 17 para. 1 MAR
Planegg/Munich, Germany, August 1, 2020
Ad hoc: FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; N [ … ]